Moderna vaccine to be used as booster doses in place of Pfizer
Senior Correspondent, bdnews24.com
Published: 13 Jan 2022 10:34 AM BdST Updated: 13 Jan 2022 10:34 AM BdST
-
File Photo
The Directorate General of Health Services, or DGHS, has ordered Moderna COVID-19 vaccines to be used in place of Pfizer shots for booster doses at vaccination centres across the country.
The Pfizer vaccine will, instead, be reserved for use as the first and second doses for students in school and college (ages 12-17) and other people who have already received one dose of the Pfizer vaccine.
The instruction was sent out to all directors of government medical colleges, the chief health officials at city colleges, government general hospitals, district central hospitals, hospitals with at least 250 beds, civil surgeons, upazila health and family welfare officials and medical officers of every municipality.
The DGHS rolled out its coronavirus booster vaccine programme on Dec 28. The doses are currently going to people over the age of 60 and frontline workers. A person becomes eligible for the third vaccine dose if at least six months have passed since they received their second.
Those who are eligible for the booster will be notified by SMS and be able to get the shot at the same vaccination centre they got their previous doses at.
Currently, Bangladesh is giving Moderna, AstraZeneca, Sinopharm and Sinovac vaccines for the first and second doses. The National Immunization Technical Advisory Group, however, has only recommended the use of Pfizer, Moderna, or AstraZeneca vaccines as boosters.
According to the DGHS count, 540,526 people have received the booster dose so far. Most of them – 270,462 – got the Pfizer vaccine. Another 247,330 got the Oxford-AstraZeneca vaccine and 22,734 got the Moderna vaccine.
-
Uterus transplants allow successful pregnancies in women: study
-
CureVac files patent lawsuit against BioNTech over mRNA technology
-
Monkeypox symptoms differ from earlier outbreaks: study
-
EU proposes ban on flavoured heated tobacco products
-
Global monkeypox cases rise to 3,400: WHO
-
Monkeypox is not yet a health emergency
-
Monkeypox case rises to more than 3,200 globally: WHO
-
US probes infant death 'related to baby formula'
-
Uterus transplants allow successful pregnancies in US women: study
-
WHO: More than 6,000 monkeypox cases reported, another emergency meeting set
-
CureVac files patent lawsuit in Germany against BioNTech over mRNA technology
-
Monkeypox symptoms differ from previous outbreaks: UK study
-
EU proposes ban on flavoured heated tobacco products
-
Monkeypox case count rises to more than 3,400 globally, WHO says
Most Read
- Life in Dhaka takes a hit as blackouts are back with vengeance
- Bangladesh is gearing up to open its first river tunnel by the end of 2022
- Ex-BCL leader sets himself on fire at Press Club in Dhaka
- Ajmer Sharif cleric arrested over 'incendiary remarks' against Nupur Sharma
- Bangladesh to celebrate Eid-ul-Azha on Jul 10
- Grim power outlook as Hasina flags surging cost amid energy crisis
- A BGB woman gives birth near Padma Bridge toll plaza
- Motorcycles banned from launches during Eid-ul-Azha
- Bangladesh brings another 2,716 education institutions under MPO coverage
- Drastic fall in passenger numbers forces owners to cut Dhaka-Barishal launch fares